Pembrolizumab plus ipilimumab for advanced melanoma: results of the keynote-029 expansion cohort

G. Long; V. Atkinson; Jonathan S. Cebon; M. B. Jameson; B. M. Fitzharris; C. M. McNeil; A. G. Hill; A. Ribas; Michael B. Atkins; J. A. Thompson; W-J Hwu; F. S. Hodi; A. M. Menzies; A. D. Guminski; R. Kefford; Xu Jie Shu; S. Ebbinghaus; N. Ibrahim; M. Carlino

Pembrolizumab plus ipilimumab for advanced melanoma: results of the keynote-029 expansion cohort

G. Long, V. Atkinson, Jonathan S. Cebon, M. B. Jameson, B. M. Fitzharris, C. M. McNeil, A. G. Hill, A. Ribas, Michael B. Atkins, J. A. Thompson, W-J Hwu, F. S. Hodi, A. M. Menzies, A. D. Guminski, R. Kefford, Xu Jie Shu, S. Ebbinghaus, N. Ibrahim, M. Carlino

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	60-61
Number of pages	2
Journal	Asia-Pacific Journal of Clinical Oncology
Volume	12
Issue number	S4
Publication status	Published - Aug 2016

Cite this

Long, G., Atkinson, V., Cebon, J. S., Jameson, M. B., Fitzharris, B. M., McNeil, C. M., Hill, A. G., Ribas, A., Atkins, M. B., Thompson, J. A., Hwu, W.-J., Hodi, F. S., Menzies, A. M., Guminski, A. D., Kefford, R., Shu, X. J., Ebbinghaus, S., Ibrahim, N., & Carlino, M. (2016). Pembrolizumab plus ipilimumab for advanced melanoma: results of the keynote-029 expansion cohort. Asia-Pacific Journal of Clinical Oncology, 12(S4), 60-61.

@article{0e73901e3ac84c0e848b38e939bed65b,

title = "Pembrolizumab plus ipilimumab for advanced melanoma: results of the keynote-029 expansion cohort",

author = "G. Long and V. Atkinson and Cebon, {Jonathan S.} and Jameson, {M. B.} and Fitzharris, {B. M.} and McNeil, {C. M.} and Hill, {A. G.} and A. Ribas and Atkins, {Michael B.} and Thompson, {J. A.} and W-J Hwu and Hodi, {F. S.} and Menzies, {A. M.} and Guminski, {A. D.} and R. Kefford and Shu, {Xu Jie} and S. Ebbinghaus and N. Ibrahim and M. Carlino",

year = "2016",

month = aug,

language = "English",

volume = "12",

pages = "60--61",

journal = "Asia-Pacific Journal of Clinical Oncology",

issn = "1743-7555",

publisher = "Wiley-Blackwell, Wiley",

number = "S4",

}

Long, G, Atkinson, V, Cebon, JS, Jameson, MB, Fitzharris, BM, McNeil, CM, Hill, AG, Ribas, A, Atkins, MB, Thompson, JA, Hwu, W-J, Hodi, FS, Menzies, AM, Guminski, AD, Kefford, R, Shu, XJ, Ebbinghaus, S, Ibrahim, N & Carlino, M 2016, 'Pembrolizumab plus ipilimumab for advanced melanoma: results of the keynote-029 expansion cohort', Asia-Pacific Journal of Clinical Oncology, vol. 12, no. S4, pp. 60-61.

TY - JOUR

T1 - Pembrolizumab plus ipilimumab for advanced melanoma

T2 - results of the keynote-029 expansion cohort

AU - Long, G.

AU - Atkinson, V.

AU - Cebon, Jonathan S.

AU - Jameson, M. B.

AU - Fitzharris, B. M.

AU - McNeil, C. M.

AU - Hill, A. G.

AU - Ribas, A.

AU - Atkins, Michael B.

AU - Thompson, J. A.

AU - Hwu, W-J

AU - Hodi, F. S.

AU - Menzies, A. M.

AU - Guminski, A. D.

AU - Kefford, R.

AU - Shu, Xu Jie

AU - Ebbinghaus, S.

AU - Ibrahim, N.

AU - Carlino, M.

PY - 2016/8

Y1 - 2016/8

M3 - Meeting abstract

SN - 1743-7555

VL - 12

SP - 60

EP - 61

JO - Asia-Pacific Journal of Clinical Oncology

JF - Asia-Pacific Journal of Clinical Oncology

IS - S4

ER -